April 15, 2026 · Form 4 insider transaction
Ramasastry Saira sold 2,000 shares of Mirum Pharmaceuticals, Inc. at $96.90 per share, a transaction worth $193.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on September 18, 2025.